FY2025 EPS Estimates for AxoGen Raised by Leerink Partnrs
AxoGen, Inc. (NASDAQ:AXGN - Free Report) - Investment analysts at Leerink Partnrs boosted their FY2025 earnings per share (EPS) estimates for AxoGen in a note issued to investors on Monday, March 31st. Leerink Partnrs analyst M. Kratky now expects that the medical equipment provider will post ear.
Publicado el: 2025-04-03 10:18:06
Autor: lulegacy, Fuente: lulegacy
Compartir: 
